| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 436.785 | 91 |
| GSM780708 | Untreated after 4 days (C2_1) | 323.744 | 88 |
| GSM780709 | Untreated after 4 days (C3_1) | 325.465 | 88 |
| GSM780719 | Untreated after 4 days (C1_2) | 404.161 | 90 |
| GSM780720 | Untreated after 4 days (C2_2) | 340.423 | 88 |
| GSM780721 | Untreated after 4 days (C3_2) | 345.735 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 288.185 | 87 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 405.899 | 90 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 363.729 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 285.741 | 87 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 433.993 | 90 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 388.546 | 90 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 437.972 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 366.214 | 89 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 440.181 | 91 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 410.999 | 90 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 403.604 | 90 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 371.884 | 89 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 427.93 | 90 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 406.75 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 341.743 | 89 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 429.651 | 90 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 378.196 | 89 |